Hologic today announced that it has been notified by Nasdaq® that the company will be added to the Nasdaq-100 Index® effective at the opening of trading on Monday, December 24, 2007. The Nasdaq-100 Index® includes 100 of the largest domestic and international non-financial securities listed on Nasdaq® based on market capitalization across major industry groups.

Hologic announced today that the FDA Obstetrics and Gynecology Devices Advisory Panel recommended that the pre-market application for Adiana® Permanent Contraception for female sterilization is Approvable. The panel reached this decision by a vote of 10 to 3.

Hologic announced today the closing of its offering of $1.725 billion aggregate original principal amount of convertible senior notes due 2037, which amount included the exercise in full by the underwriters of the $225 million overallotment option granted to them by Hologic.

Hologic today announced that Patrick Sullivan, Executive Chairman and Glenn Muir, Chief Financial Officer, will participate in the RBC Capital Markets 2007 Healthcare Conference being held December 12-13, 2007 at the Westin Times Square Hotel in New York.

Hologic announced today the pricing of $1.5 billion aggregate principal amount of convertible senior notes due 2037.

Hologic announced today its intention to offer to sell, subject to market and other conditions, $1.3 billion aggregate principal amount of convertible senior notes due 2037 pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The Company expects to grant to the underwriters an option to purchase up to an additional $195 million aggregate principal amount of notes to cover overallotments. Goldman, Sachs & Co. is acting as sole book-running manager of the offering.

Hologic today announced the Company will host a meeting for members of the investment community who will be attending the RSNA (Radiological Society of North America ) trade show in Chicago.

Hologic today announced that twenty-two scientific abstracts evaluating the performance of the ThinPrep® System were presented this week at the 55th Annual Scientific Meeting of the American Society of Cytopathology (ASC) in Houston, Texas. Eleven of these studies featured the ThinPrep® Imaging System and evaluated a number of screening parameters including disease detection compared to manual screening of ThinPrep Pap Tests, detection of glandular abnormalities, and impact on overall quality and productivity.

Hologic today announced that Patrick Sullivan, Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the Stephens Fall Investment Conference being held November 14-15, 2007 at the New York Palace Hotel in New York, NY.

Hologic today announced that Patrick Sullivan, Chairman and Glenn Muir, Chief Financial Officer, will be presenting at the CIBC World Markets 18th Annual Healthcare Conference being held November 5-7, 2007 at the Waldorf Astoria Hotel in New York, NY.

Hologic today announced plans to release its fourth quarter and fiscal 2007 operating results on Tuesday, November 6, 2007 at 8:00 a.m. (Eastern). In conjunction with the release, management will host a conference call on Tuesday, November 6, 2007 at 9:00 a.m. (Eastern).

Hologic and Cytyc Corporation today announced the completion of the combination of the two companies, creating one of the largest companies in the world focused on advanced technology in women’s health.

Hologic today announced that its stockholders voted overwhelmingly at a Special Meeting of Stockholders to approve the transactions contemplated by Hologic’s previously announced merger with Cytyc.

Hologic today announced that ISS, the leading independent proxy advisory service, recommends that Hologic stockholders vote “FOR” the Company’s proposed merger with Cytyc Corporation (NASDAQ: CYTC).

Cytyc Corporation announced that the first four Cellient(TM) Automated Cell Block Systems were shipped this week. The Cellient units were sent to Veteran's Administration Medical Centers in West Roxbury, MA and Charleston, SC, to New England Pathology Associates at Mercy Medical Center in Springfield, MA, and to Susquehanna Health Williamsport Hospital in Williamsport, Pennsylvania. The Cellient instrument is a fully automated system that allows individual cells or small tissue samples to be processed for histological examination.

Hologic today announced it will open the NASDAQ Stock Market tomorrow, October 2, 2007, in New York at 9:30AM ET in recognition of National Breast Cancer Awareness Month, commemorated annually on October 1st. The Company has been listed on NASDAQ for seventeen years. Chairman and CEO of Hologic, Jack Cumming, will preside over the NASDAQ opening bell ceremony at the NASDAQ Market Site, located at 4 Times Square, New York City.

Hologic today announced it has completed the acquisition of BioLucent, Inc. (“BioLucent”), a market leader in its development and sale of its MammoPad® breast cushion.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the UBS Global Life Sciences Conference being held September 24 - 27, 2007 at the Grand Hyatt Hotel in New York, NY.

Hologic today announced that its registration statement, including a joint proxy statement/prospectus, for a business combination with Cytyc Corporation (Nasdaq: CYTC), has become effective. The Company will commence mailing definitive proxy materials in connection with the Company’s merger agreement with Cytyc to stockholders early next week.

Hologic today announced announced the publication of the first large scale study comparing the results of a particular digital mammography technology to women screened with film.

Hologic today announced plans to release its third quarter fiscal 2007 operating results on Tuesday, July 31, 2007 at 8:00 a.m. (eastern). In conjunction with the release, management will host a conference call on Tuesday, July 31, 2007 at 9:30 a.m. (eastern).

Cytyc Corporation today announced that a new, independent Australian study evaluating the ThinPrep Imaging System is featured in a recent issue of the British Medical Journal (BMJ). The July 7, 2007 edition of the BMJ, titled "Advantages of Liquid Based Cytology," also includes a commentary describing the ThinPrep Imaging System and an editorial confirming the advantages of this technology.

Hologic and Cytyc Corporation today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, in connection with the companies? pending merger.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer and Glenn Muir, Chief Financial Officer, will be presenting at the Jefferies Healthcare Conference being held June 26-28, 2007 at the Mandarin Oriental Hotel in New York, NY.

Hologic today announced it has entered into a definitive agreement to acquire BioLucent, Inc. and its MammoPad breast cushion business. Concurrently with the closing of the transaction, Biolucent will spin-off its brachytherapy business into a newly created company, which will remain an independent company.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer will be presenting at the NASDAQ 19th Investor Program being held June 19, 2007 at the Renaissance Chancery Court Hotel in London and June 20, 2007 at the Hotel Baur au Lac in Zurich.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer and Glenn Muir, Chief Financial Officer, will be presenting at the Sixth Annual Needham & Company Biotechnology & Medical Technology Conference being held June 13 - 14, 2007 at the New York Palace Hotel in New York, NY.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer will be presenting at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference being held June 11 - 14, 2007 at the Ritz-Carlton Laguna Niguel Hotel in Dana Point, CA.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer and Glenn Muir, Chief Financial Officer, will be presenting at the Bank of America Healthcare Conference being held May 30 - June 1, 2007 at the Four Seasons Hotel in Las Vegas, NV.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the FBR Growth Conference being held May 30 - 31, 2007 at the Grand Hyatt Hotel in New York, NY.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer and Glenn Muir, Chief Financial Officer, will be presenting at the Citigroup Global Healthcare Conference being held May 22-24, 2007 at the New York Hilton Hotel in New York, NY.

Hologic and Cytyc Corp. today announced a definitive agreement to combine the two companies in a cash and stock transaction. This strategic combination, unanimously approved by the Boards of Directors of both companies, will create a $10 billion global leader in women?s healthcare.

Hologic today announced that Rob Cascella, President and Chief Operating Officer and Glenn Muir, Chief Financial Officer, will be presenting at the Bank of America Small/Mid Cap Conference being held May 16-17, 2007 at the Four Seasons Hotel in Boston, MA

Cytyc Corporation through its Cytyc Development Company, LLC subsidiary, has made a venture investment in Combinent BioMedical Systems, an early stage company developing a vaginal drug delivery platform for delivering a combination of drugs, currently given orally and intravenously, in a single device. Optimized delivery of several drug combinations is expected to greatly improve treatment of a number of women's health diseases with large markets and high unmet needs.

Hologic today announced plans to release its second quarter fiscal 2007 operating results on Tuesday, May 1, 2007 at 8:00 a.m. (eastern).

Hologic announced today the company has been selected as the recipient of the 2007 Frost & Sullivan awards for Market Leadership and Product Line Strategy.

Hologic today announced that Rob Cascella, President and Chief Operating Office and Glenn Muir, Chief Financial Officer, will be presenting at the Citigroup 2007 Small & Mid-Cap Conference being held March 13-15, 2007 at the Four Seasons Hotel in Las Vegas, NV.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Raymond James & Associates 28th Annual Institutional Investors Conference being held March 4-7, 2007 at the Hyatt Regency Grand Cypress in Orlando, FL.

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Susquehanna Financial Group?s Significant Investment Options in Healthcare Conference being held March 1, 2007 at the Omni Berkshire Place in New York, NY.

Cytyc Corporation today announced that a new clinical guideline for Heavy Menstrual Bleeding (HMB), published this month by the UK National Institute for Health and Clinical Excellence (NICE), recommends endometrial ablation as preferable to hysterectomy for the treatment of most women who suffer from heavy menstrual bleeding alone. The new guideline was developed by the National Collaborating Centre for Women's And Children's Health, which is based in the Royal College of Obstetricians and Gynecologists.

Hologic , today announced plans to release its first quarter fiscal 2007 operating results on Wednesday, January 31, 2007 at 8:00 a.m. (eastern).

Hologic today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Ninth Annual Needham & Company Growth Conference being held January 9-12, 2007 at the Palace Hotel in New York, NY.

Hologic today announced that Jack Cumming, Chairman and Chief Executive Officer, and Glenn Muir, Chief Financial Officer, will be presenting at the 25th Annual JP Morgan Healthcare Conference being held January 8-11, 2007 at the Westin St. Francis Hotel in San Francisco, CA.